# Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery

> **NCT04785521** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 100 (estimated)

## Conditions studied

- Brain Metastases, Adult

## Interventions

- **RADIATION:** Stereotactic radiosurgery
- **DIAGNOSTIC_TEST:** Blood samples

## Key facts

- **NCT ID:** NCT04785521
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785521, "Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04785521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*